CymaBay Therapeutics Banner Image

CymaBay Therapeutics

  • Ticker CBAY
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
CymaBay Therapeutics Logo Image
  • 11-50 Employees
  • Based in Newark, California
CymaBay Therapeutics, Inc. (CBAY) is a clinical-stage biopharmaceutical company developing therapies to treat metabolic diseases with high unmet medical need, including serious rare and orphan disorders. MBX-8025 is a potent, selective, orally active PPARδ agonist.
CymaBay Therapeutics

Most Recent Annual Report

CymaBay Therapeutics MOST RECENT 2019 Annual Report and Form 10K

Report Locked. CymaBay Therapeutics has reached its limit for free report views.

Older/Archived Annual Reports